VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 43 filers reported holding VIRACTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,583,093 | -26.4% | 1,522,204 | -0.2% | 0.00% | – |
| Q2 2023 | $2,150,028 | -13.3% | 1,524,843 | -2.2% | 0.00% | -100.0% |
| Q1 2023 | $2,480,119 | +7.5% | 1,559,823 | -1.3% | 0.00% | 0.0% |
| Q4 2022 | $2,306,535 | -67.3% | 1,579,819 | -4.5% | 0.00% | -50.0% |
| Q3 2022 | $7,064,000 | +8.9% | 1,654,155 | -1.1% | 0.00% | 0.0% |
| Q2 2022 | $6,488,000 | -19.8% | 1,672,162 | -1.6% | 0.00% | 0.0% |
| Q1 2022 | $8,087,000 | +40.7% | 1,698,854 | +7.9% | 0.00% | +100.0% |
| Q4 2021 | $5,748,000 | -54.5% | 1,574,601 | -0.1% | 0.00% | -66.7% |
| Q3 2021 | $12,646,000 | -29.2% | 1,576,846 | +0.1% | 0.00% | -25.0% |
| Q2 2021 | $17,862,000 | +23.2% | 1,575,174 | +0.5% | 0.00% | +33.3% |
| Q1 2021 | $14,496,000 | – | 1,567,082 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 689,709 | $1,096,637 | 0.23% |
| Aisling Capital Management LP | 288,571 | $458,828 | 0.22% |
| BVF INC/IL | 3,614,662 | $5,747,313 | 0.21% |
| Rubric Capital Management LP | 1,487,385 | $2,364,942 | 0.06% |
| HAMILTON LANE ADVISORS LLC | 35,791 | $57 | 0.02% |
| MAI Capital Management | 379,468 | $603,354 | 0.01% |
| Laurion Capital Management LP | 698,000 | $1,109,820 | 0.01% |
| TRUST CO OF TOLEDO NA /OH/ | 28,000 | $44,520 | 0.01% |
| RP Management, LLC | 3,700 | $5,883 | 0.01% |
| Jasper Ridge Partners, L.P. | 92,939 | $147,773 | 0.01% |